Retrospective analysis of 80 cases with uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma in China, 1988-2007

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 4, 2014, Pages 1616-1624

  Gao, Yuan ^a,b   Meng, Hao ^b,c   Zhang, Yemin ^a   Jiao, Tingting ^a   Hui, Ning ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c AIR FORCE GENERAL HOSPITAL   (China)

Author keywords

Blood type; Carcinosarcoma; China; Endometrial stromal sarcoma; Leiomyosarcoma; Prognosis

Indexed keywords

ADULT; AGED; CANCER STAGING; CARCINOSARCOMA; CHINA; ENDOMETRIAL NEOPLASMS; FEMALE; GYNECOLOGIC SURGERY; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; LEIOMYOSARCOMA; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SARCOMA, ENDOMETRIAL STROMAL; SURVIVAL RATE; UTERINE NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOSARCOMA; CHINA; ENDOMETRIAL NEOPLASMS; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LEIOMYOSARCOMA; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SARCOMA, ENDOMETRIAL STROMAL; SURVIVAL RATE; UTERINE NEOPLASMS;

EID: 84899525358     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Parker WH. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol 2005; 105: 216-217.
2. Akahira J, Tokunaga H, Toyoshima M, Takano T, Nagase S, Yoshinaga K, Tase T, Wada Y, Ito K, Niikura H, Yamada H, Sato A, Sasano H, Yaegashi N. Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma. Oncology 2006; 71: 333-340.
3. Bocker W. [WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics]. Verh Dtsch Ges Pathol 2002; 86: 116-119.
4. Chauveinc L, Deniaud E, Plancher C, Sastre X, Amsani F, de la Rochefordiere A, Rozemberg H, Clough KB. Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments. Gynecol Oncol 1999; 72: 232-237.
5. Kokawa K, Nishiyama K, Ikeuchi M, Ihara Y, Akamatsu N, Enomoto T, Ishiko O, Motoyama S, Fujii S, Umesaki N. Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990-2003). Int J Gynecol Cancer 2006; 16: 1358-1363.
6. D'Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol 2010; 116: 131-139.
7. Koivisto-Korander R, Butzow R, Koivisto AM, Leminen A. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001. Gynecol Oncol 2008; 111: 74-81.
8. Durnali A, Tokluoglu S, Ozdemir N, Inanc M, Alkis N, Zengin N, Sonmez OU, Kucukoner M. Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey. Asian Pac J Cancer Prev 2012; 13: 1935-1941.
9. Piura B, Rabinovich A, Yanai-Inbar I, Cohen Y, Glezerman M. Uterine sarcoma in the south of Israel: study of 36 cases. J Surg Oncol 1997; 64: 55-62.
10. Wickerham DL, Fisher B, Wolmark N, Bryant J, Costantino J, Bernstein L, Runowicz CD. Association of tamoxifen and uterine sarcoma. J Clin Oncol 2002; 20: 2758-2760.
11. Wolpin BM, Chan AT, Hartge P, Chanock SJ, Kraft P, Hunter DJ, Giovannucci EL, Fuchs CS. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009; 101: 424-431.
12. Kabir A. Comment on: Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case-control study. J Korean Med Sci 2013; 28: 1114.
13. Woo SM, Joo J, Lee WJ, Park SJ, Han SS, Kim TH, Koh YH, Kim HB, Hong EK. Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case-control study. J Korean Med Sci 2013; 28: 247-251.
14. Gong Y, Yang YS, Zhang XM, Su M, Wang J, Han JD, Guo MZ. ABO blood type, diabetes and risk of gastrointestinal cancer in northern China. World J Gastroenterol 2012; 18: 563-569.
15. Dede DS, Aksoy S, Dizdar O, Cerci P, Gullu I, Ozisik Y, Altundag K. Blood ABO groups and risk of breast cancer. Med Oncol 2010; 27: 1433.
16. Urun Y, Utkan G, Altundag K, Arslan O, Onur H, Arslan UY, Kocer M, Dogan I, Senler FC, Yalcin B, Demirkazik A, Akbulut H, Icli F. ABO and Rh blood groups frequency in women with HER2 positive breast cancer. J BUON 2012; 17: 457-460.
17. Jaleel BF, Nagarajappa R. Relationship between ABO blood groups and oral cancer. Indian J Dent Res 2012; 23: 7-10.
18. Yuzhalin AE, Kutikhin AG. ABO and Rh blood groups in relation to ovarian, endometrial and cervical cancer risk among the population of South-East Siberia. Asian Pac J Cancer Prev 2012; 13: 5091-5096.
19. Wolfson AH, Wolfson DJ, Sittler SY, Breton L, Markoe AM, Schwade JG, Houdek PV, Averette HE, Sevin BU, Penalver M, et al. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas. Gynecol Oncol 1994; 52: 56-62.
20. Wang J, Yang J, Huang H, Li Y, Miao Q, Lu X, Yang N, Huang Y, Chen J, Cao D, Wu M, Pan L, Lang J, Shen K. Management of intravenous leiomyomatosis with intracaval and intracardiac extension. Obstet Gynecol 2012; 120: 1400-1406.
21. Gunthert AR. Sarcomas and mixed mesodermal tumors of the uterus. Ther Umsch 2011; 68: 559-564.
22. Anyiam DC, Ukah CO, Onyiaorah IV, Okafor N. Sarcoma botyroides of the cervix in a HIV positive 45-year-old woman: a case report. Niger J Clin Pract 2010; 13: 341-343.
23. Ghaemmaghami F, Karimi-Zarchi M, Gilani MM, Mousavi A, Behtash N, Ghasemi M. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran. Asian Pac J Cancer Prev 2008; 9: 421-426.
24. Fekete PS, Vellios F. The clinical and histologic spectrum of endometrial stromal neoplasms: a report of 41 cases. Int J Gynecol Pathol 1984; 3: 198-212.
25. Gadducci A. Prognostic factors in uterine sarcoma. Best Pract Res Clin Obstet Gynaecol 2011; 25: 783-795.
26. Leitao MM, Sonoda Y, Brennan MF, Barakat RR, Chi DS. Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus. Gynecol Oncol 2003; 91: 209-212.
27. Temkin SM, Hellmann M, Lee YC, Abulafia O. Early-stage carcinosarcoma of the uterus: the significance of lymph node count. Int J Gynecol Cancer 2007; 17: 215-219.
28. Kahanpaa KV, Wahlstrom T, Grohn P, Heinonen E, Nieminen U, Widholm O. Sarcomas of the uterus: a clinicopathologic study of 119 patients. Obstet Gynecol 1986; 67: 417-424.
29. Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH. The impact of tumor morcellation during surgery on the outcomes of patients with apparently early low-grade endometrial stromal sarcoma of the uterus. Ann Surg Oncol 2011; 18: 3453-3461.
30. Benito V, Lubrano A, Arencibia O, Andujar M, Alvarez E, Medina N, Falcon JM, Falcon O. Clinicopathologic analysis of uterine sarcomas from a single institution in the Canary Islands. Int J Gynaecol Obstet 2009; 107: 44-49.